Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19512303 | 1.00 | LMNA (0.40) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL16915296 | 1.00 | LMNA (0.40) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL18383123 | 0.87 | AKR1B1 (0.33) | LMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL5496629 | 0.87 | AKR1B1 (0.33) | LMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL10507472 | 0.84 | LMNA (0.37) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL7953192 | 0.81 | PDE4A (0.38) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL28259629 | 0.80 | USP2 (0.35) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL15689286 | 0.80 | LMNA (0.33) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| SCHEMBL28085985 | 0.79 | AKR1B1 (0.31) | AKR1B1 | |
| SCHEMBL11858560 | 0.78 | LMNA (0.43) | LMNAL3MBTL1TDP1PDE4AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4365189-B1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | HOFFMANN LA ROCHE (CH) | 2025-02-19 | — | — | EP | claimed |
| CN-112480255-B | Prevention of disulfide bond reduction during recombinant production of polypeptides | 健泰科生物技术公司 | 2024-09-27 | — | — | CN | claimed |
| US-12098211-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-09-24 | — | — | US | claimed |
| US-11987638-B1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-05-21 | — | — | US | claimed |
| US-20240158527-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-05-16 | — | — | US | claimed |
| EP-4365189-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-05-08 | — | — | EP | claimed |
| EP-4335863-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| EP-4245766-A9 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2024-01-24 | — | — | EP | claimed |
| US-20230383004-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2023-11-30 | — | — | US | claimed |
| EP-4245766-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| US-11639395-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2023-05-02 | — | — | US | claimed |
| US-20210188993-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2021-06-24 | — | — | US | claimed |
| WO-2020028616-A1 | METHODS FOR MANUFACTURING RECOMBINANT PROTEIN COMPRISING A DISULFIDE BOND | LONZA LTD (CH) | 2020-02-06 | — | — | WO | claimed |
| EP-3327026-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2018-05-30 | — | — | EP | claimed |
| EP-2188302-B1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH INC (US) | 2017-11-01 | — | — | EP | claimed |
| US-20140128575-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2014-05-08 | — | — | US | claimed |
| EP-2586788-A1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Genentech, Inc. (US) | 2013-05-01 | — | — | EP | claimed |
| US-20130017598-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2013-01-17 | — | — | US | claimed |
| US-20090053786-A1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. | 2009-02-26 | — | — | US | claimed |
| US-12528875-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20260008863-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2026-01-08 | — | — | US | disclosed |
| US-12466874-B2 | Prevention of protein disulfide bond reduction | MEDIMMUNE LLC (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250243291-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4365189-B1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | HOFFMANN LA ROCHE (CH) | 2025-02-19 | — | — | EP | disclosed |
| CN-119241636-A | Prevention of disulfide bond reduction during recombinant production of polypeptides | 健泰科生物技术公司 | 2025-01-03 | — | — | CN | disclosed |
| US-20240425610-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-12-26 | — | — | US | disclosed |
| US-12173080-B1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-12145997-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-11-19 | — | — | US | disclosed |
| CN-112480255-B | Prevention of disulfide bond reduction during recombinant production of polypeptides | 健泰科生物技术公司 | 2024-09-27 | — | — | CN | disclosed |
| US-12098211-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-09-24 | — | — | US | disclosed |
| US-20240301080-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-09-12 | — | — | US | disclosed |
| US-11999791-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| US-11987637-B1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-11987638-B1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-20240158527-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-20240150486-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-05-09 | — | — | US | disclosed |
| EP-4365189-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-05-08 | — | — | EP | disclosed |
| US-11976127-B1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2024-05-07 | — | — | US | disclosed |
| US-20240132612-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-04-25 | — | — | US | disclosed |
| EP-4335863-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-4245766-A9 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20230383004-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230365704-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| EP-4245766-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2023-09-20 | — | — | EP | disclosed |
| EP-4219522-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11639395-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2023-05-02 | — | — | US | disclosed |
| EP-3597659-B1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH INC (US) | 2023-03-01 | — | — | EP | disclosed |
| US-20220098282-A1 | PREVENTION OF PROTEIN DISULFIDE BOND REDUCTION | MEDIMMUNE LLC | 2022-03-31 | — | — | US | disclosed |
| US-11078294-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| US-20210188993-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2021-06-24 | — | — | US | disclosed |
| US-20210095040-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2021-04-01 | — | — | US | disclosed |
| CN-112480255-A | Prevention of disulfide bond reduction during recombinant production of polypeptides | 健泰科生物技术公司 | 2021-03-12 | — | — | CN | disclosed |
| US-10906986-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2021-02-02 | — | — | US | disclosed |
| US-20200347145-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2020-11-05 | — | — | US | disclosed |
| US-10808037-B1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2020-10-20 | — | — | US | disclosed |
| US-20200317801-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2020-10-08 | — | — | US | disclosed |
| US-10759866-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2020-09-01 | — | — | US | disclosed |
| WO-2020028616-A1 | METHODS FOR MANUFACTURING RECOMBINANT PROTEIN COMPRISING A DISULFIDE BOND | LONZA LTD (CH) | 2020-02-06 | — | — | WO | disclosed |
| EP-3327026-B1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH INC (US) | 2019-08-21 | — | — | EP | disclosed |
| US-20190135935-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2019-05-09 | — | — | US | disclosed |
| US-20190112357-A1 | PREVENTION OF PROTEIN DISULFIDE BOND REDUCTION | MEDIMMUNE LLC | 2019-04-18 | — | — | US | disclosed |
| EP-3454890-A1 | PREVENTION OF PROTEIN DISULFIDE BOND REDUCTION | MedImmune, LLC (US) | 2019-03-20 | — | — | EP | disclosed |
| EP-3327026-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2018-05-30 | — | — | EP | disclosed |
| EP-2586788-B1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH INC (US) | 2017-11-29 | — | — | EP | disclosed |
| WO-2017196810-A1 | PREVENTION OF PROTEIN DISULFIDE BOND REDUCTION | MEDIMMUNE, LLC (US) | 2017-11-16 | — | — | WO | disclosed |
| US-20170313780-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2017-11-02 | — | — | US | disclosed |
| EP-2188302-B1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH INC (US) | 2017-11-01 | — | — | EP | disclosed |
| US-20140128575-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2014-05-08 | — | — | US | disclosed |
| US-8574869-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. (US) | 2013-11-05 | — | — | US | disclosed |
| EP-2586788-A1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Genentech, Inc. (US) | 2013-05-01 | — | — | EP | disclosed |
| US-20130017598-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2013-01-17 | — | — | US | disclosed |
| EP-2188302-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2010-05-26 | — | — | EP | disclosed |
| US-20090053786-A1 | Prevention of disulfide bond reduction during recombinant production of polypeptides | GENENTECH, INC. | 2009-02-26 | — | — | US | disclosed |
| WO-2009009523-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2009-01-15 | — | — | WO | disclosed |
| WO-2009009523-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528875-B2 | Prevention of disulfide bond reduction during recombinant production of polypeptides | TXN, TXNRD1, TXNRD3 | LMNA 4607/4885L3MBTL1 3552/4885TDP1 2622/4885 |
| US-20260008863-A1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | TXN, TXNRD1, TXNRD3 | LMNA 4610/4885L3MBTL1 3594/4885TDP1 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.